Opioid Use Disorder: Moving Beyond the Status Quo to Save Lives

1.50 CME
$0 FEE
Family Medicine


Provider Statement

This continuing medical education activity is provided by Vindico Medical Education.

Support Statement

 This activity is supported by an educational grant from Indivior, Inc.

Target Audience

The intended audience for this activity is family practice physicians, internists, psychiatrists, and other health care professionals involved in the treatment of patients with opioid use disorder (OUD).

Learning Objectives

Upon successful completion of this educational activity, participants should be better able to:

  • Identify patients with or at risk for opioid use disorder (OUD). 
  • Counsel patients and provide interventions that may prevent further substance abuse. 
  • Use evidence-based modalities that improve patients’ access to medical treatment for OUD. 
  • Incorporate the use of evidence-based therapies and their formulations for the treatment of OUD in patients.

Activity Chair

Genie L. Bailey, MD
Clinical Associate Professor of Psychiatry and Human Behavior 
Warren Alpert Medical School of Brown University 
Providence, RI
Director of Research and Director of Medications for Addiction Treatment Division
Stanley Street Treatment and Resources, Inc. 
Fall River, MA


Stephen M. Taylor, MD, MPH, FASAM 
General, Child/Adolescent and Addiction Psychiatrist 
Medical Director 
NBA/NBPA Player Assistance/Anti-Drug Program 
Birmingham, AL

Steven L. Wright, MD, FAAFP, FASAM 
Consultant, Addiction Medicine and Medical Pain Management 
Wright Medical, LLC 
Littleton, CO 
Medical Director 
Mountain Medical Care 
Denver, CO


Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP


Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This Enduring Material activity, Opioid Use Disorder: Moving Beyond the Status Quo to Save Lives, has been reviewed and is acceptable for up to 1.50 Prescribed credit(s) by the American Academy of Family Physicians. AAFP certification begins 12/14/2018. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, December 14, 2018 through December 13, 2019.

AMA/AAFP Equivalency

AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.

How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 of the 3 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.


In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Activity Chair and Faculty report the following relationships

Genie L. Bailey, MD
Consulting Fee: Alkermes, Braeburn
Speakers Bureau:
Contracted Research:
Travel Support:
Alkermes, Braeburn

Stephen M. Taylor, MD, MPH, FASAM
Consulting Fee: Pathway Healthcare
Ownership Interest:
Pathway Healthcare

Steven L. Wright, MD, FAAFP, FASAM
Consulting Fee: AstraZeneca, Boehringer Ingelheim, Gilead, Sanofi Regeneron, The Medicines Company
Speakers Bureau:
US World Meds

Reviewer reports the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2018 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at cme@vindicoCME.com